Craniofacial Phenotypes and Genetics of DiGeorge Syndrome

Area of Science:

• Genetics
• Developmental Biology
• Medical Genetics

Background:

• 22q11.2 deletion syndrome, encompassing DiGeorge syndrome (DGS) and velocardiofacial syndrome (VCFS), is a common human microdeletion affecting ~1 in 4000 live births.
• This syndrome is characterized by cardiac malformations, immune deficiency (thymic hypoplasia), hypoparathyroidism, and a spectrum of craniofacial anomalies.
• Craniofacial defects in DGS/VCFS involve the cranium, cranial base, jaws, pharyngeal structures, palate, teeth, and cervical spine, often linked to proximal 1.5 Mb deletions.

Purpose of the Study:

• To provide a comprehensive review of the craniofacial phenotypes associated with 22q11.2 deletion syndrome (DGS/VCFS).
• To summarize the current understanding of genetic factors contributing to DGS/VCFS-related craniofacial anomalies.
• To discuss the utility of DGS/VCFS mouse models in elucidating pathogenic mechanisms.

Main Methods:

• Literature review focusing on craniofacial phenotypes in DGS/VCFS.
• Analysis of genetic factors, including the role of the TBX1 gene.
• Examination of findings from DGS/VCFS mouse models.

Main Results:

• The 22q11.2 deletion frequently results in diverse craniofacial abnormalities affecting multiple structures.
• The TBX1 gene, a transcription factor crucial for embryonic development, is a key candidate gene implicated in DGS/VCFS phenotypes.
• Tbx1-null mouse models recapitulate many clinical features of DGS/VCFS, including craniofacial defects, aiding in understanding disease mechanisms.

Conclusions:

• Craniofacial phenotypes are a significant and prevalent feature of 22q11.2 deletion syndrome.
• Understanding the genetic basis, particularly the role of TBX1, is crucial for comprehending DGS/VCFS pathogenesis.
• DGS/VCFS mouse models serve as valuable tools for studying the developmental basis of these complex phenotypes.